HOLOXAN 500MG Prášek pro infuzní roztok Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

holoxan 500mg prášek pro infuzní roztok

baxter czech spol. s r.o., praha array - 7269 ifosfamid - prášek pro infuzní roztok - 500mg - ifosfamid

HOLOXAN 2G Prášek pro infuzní roztok Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

holoxan 2g prášek pro infuzní roztok

baxter czech spol. s r.o., praha array - 7269 ifosfamid - prášek pro infuzní roztok - 2g - ifosfamid

HOLOXAN 1G Prášek pro infuzní roztok Tsjekkia - tsjekkisk - SUKL (Státní ústav pro kontrolu léčiv)

holoxan 1g prášek pro infuzní roztok

baxter czech spol. s r.o., praha array - 7269 ifosfamid - prášek pro infuzní roztok - 1g - ifosfamid

HOLOXAN 2g powder for injection vial Australia - engelsk - Department of Health (Therapeutic Goods Administration)

holoxan 2g powder for injection vial

baxter healthcare pty ltd - ifosfamide, quantity: 2 g - injection, powder for - excipient ingredients: - use in the treatment of tumours sensitive to ifosfamide either as a single agent or in combination with other chemotherapeutic agents. tumour types that have been demonstrated to respond to ifosfamide single agent or in combination are germ cell tumours, sarcomas, lymphomas. anti-tumour activity has been shown in ovarian and cervical cancers. some activity has also been seen in lung and breast cancer.

HOLOXAN 1g powder for injection vial Australia - engelsk - Department of Health (Therapeutic Goods Administration)

holoxan 1g powder for injection vial

baxter healthcare pty ltd - ifosfamide, quantity: 1 g - injection, powder for - excipient ingredients: - use in the treatment of tumours sensitive to ifosfamide either as a single agent or in combination with other chemotherapeutic agents. tumour types that have been demonstrated to respond to ifosfamide single agent or in combination are germ cell tumours, sarcomas, lymphomas. anti-tumour activity has been shown in ovarian and cervical cancers. some activity has also been seen in lung and breast cancer.

Holoxan, poeder voor oplossing voor infusie Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

holoxan, poeder voor oplossing voor infusie

baxter b.v. kobaltweg 49 3542 ce utrecht - ifosfamide 500 mg/flacon ; ifosfamide 1 g/flacon ; ifosfamide 2 g/flacon - poeder voor oplossing voor infusie - geen hulpstoffen, - ifosfamide

Holoxan 500 mg inj. opl. (pdr.) i.v. flac. Belgia - nederlandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

holoxan 500 mg inj. opl. (pdr.) i.v. flac.

baxter sa-nv - ifosfamide 500 mg - poeder voor oplossing voor injectie - 500 mg - ifosfamide 500 mg - ifosfamide